|
Galenix was founded in 1993 by its CEO, Mr Jérôme Besse.
The company is now ranked in the top European leaders for
Pharmaceutical R&D and Drug Delivery Systems.
Galenix provides
comprehensive pharmaceutical development services to healthcare
companies, from the sourcing of the Active Pharmaceutical Ingredient
(API) to the clinical/pilot batches production and regulatory submission.
Its two major competitive strengths, in addition to a full service delivery,
are the compliance of the c.G.M.P. facilities with European and American standards,
as well as its extensive know-how and experience in innovative Drug Delivery Systems design and patent.
|
 |
|
|
|
